NGMedical to showcase cervical disc portfolio at CSRS and DWG
NGMedical GmbH will present its cervical motion-preservation portfolio at two spine congresses in December, including the CSRS Annual Meeting in Austin and the German Spine Society meeting in Nuremberg. The company will highlight its MOVE-C artificial disc and recent international expansion as it courts surgeons and grows its market reach.
Why it matters: - NGMedical is using two major spine meetings to reach surgeons in North America and Germany. - The company is positioning MOVE®-C as a next-generation cervical disc option in a market focused on motion preservation. - The events give NGMedical a platform to support its international expansion after adding 7 new countries in 2026.
What happened: - NGMedical GmbH said it will exhibit at the Cervical Spine Research Society Annual Meeting in Austin and at the Annual Congress of the German Spine Society in Nuremberg. - The Austin meeting runs Dec. 2-4, and NGMedical will be at booth #409. - The Nuremberg meeting runs Dec. 9-11, and NGMedical will be at booth #A41. - The company will present its product portfolio at both congresses. - NGMedical said the team will discuss the next generation of cervical disc arthroplasty with spine surgeons.
The details: - MOVE®-C is described as the only articulating-viscoelastic cervical artificial disc. - The company says MOVE®-C has nearly 7 years of clinical experience. - NGMedical says MOVE®-C has demonstrated safety and function in everyday clinical practice. - NGMedical says MOVE®-C is driving its international expansion. - The company says 7 new countries were added in 2026. - The portfolio available for review includes the MOVE®-C prosthesis and NGMedical's broader spinal implant lineup. - The company also points to motion-preserving technologies such as MOVE®-P and fusion products. - For more information, visit the company's webpage.
Between the lines: - The exhibit strategy suggests NGMedical wants to reinforce its clinical credibility with surgeons before and during product adoption decisions. - By highlighting experience, safety and international growth at specialty congresses, NGMedical is signaling both maturity and ambition in a competitive spine-device market. - CEO Peter Weiland said the CSRS and DWG events bring together surgeons shaping spine care and that scientific dialogue is valuable to the company.
What's next: - NGMedical will meet attendees in Austin and Nuremberg during the December congresses. - The company is likely to use the meetings to expand surgeon awareness of MOVE®-C and its broader motion-preservation portfolio. - The next visible milestone is whether the 2026 expansion and conference outreach translate into broader clinical and commercial uptake.
The bottom line: - NGMedical is taking its cervical disc push directly to two key surgeon audiences as it aims to deepen adoption and extend its international footprint.
Disclaimer: This article was produced by AGP Wire with the assistance of artificial intelligence based on original source content and has been refined to improve clarity, structure, and readability. This content is provided on an “as is” basis. While care has been taken in its preparation, it may contain inaccuracies or omissions, and readers should consult the original source and independently verify key information where appropriate. This content is for informational purposes only and does not constitute legal, financial, investment, or other professional advice.
Sign up for:
Investor News Updates
The daily local news briefing you can trust. Every day. Subscribe now.
Check Your Email!
We sent a one-time activation link to: .
Confirm it's you by clicking the email link.
If the email is not in your inbox, check spam or try again.
Welcome back!
is already signed up. Check your inbox for updates.